ArticleFrontiers in medicine2025

Mepyramine targets mutant Nav1.7 channels to relieve pain and erythema in primary erythromelalgia patients.

Myriam Ducrocq et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.